Search research articles
Contact Us
Filters
Showing results (941-950 of 1,174) with videos related to
Page
of 118
Sort By:
Current Protein & Peptide Science
|
May 27, 2020
The Advances of the Structure and Function of Indoleamine 2, 3- dioxygenase 1 and Its Inhibitors
Huai-Chuan Duan, Lian-Xin Peng, Yi-Chen Hu, et al.
Environment International
|
October 29, 2021
Heterogeneous viral contribution to dissolved organic matter processing in a long-term macrocosm experiment
Xiaowei Chen, Wei Wei, Xilin Xiao, et al.
Current Medical Science
|
April 28, 2023
Efficacy of Children Neuropsychological and Behavioral Scale in Screening for Autism Spectrum Disorders through a Combination of Developmental Surveillance
Jin-Hui Li, Jin-Zhu Zhao, Li Hua, et al.
Biotechnology and Bioengineering
|
January 14, 2019
Combining orthogonal CRISPR and CRISPRi systems for genome engineering and metabolic pathway modulation in Escherichia coli
Li-Yu Sung, Meng-Ying Wu, Mei-Wei Lin, et al.
Oncotargets and Therapy
|
May 27, 2016
Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis
Yong-Xuan Liu, Xin-Shuai Wang, Yu-Feng Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 30, 2020
Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer
Weili Wang, Martha M Matuszak, Chen Hu, et al.
Experimental Cell Research
|
May 8, 2020
Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia
Cheng Chen, Li Wang, Lili Li, et al.
The Review of Scientific Instruments
|
December 30, 2025
Tabletop pulsed x-ray ghost imaging with a single-pixel detector
Hui Zeng, Ming-Yang Zhu, Xi-Chen Hu, et al.
Mabs
|
November 5, 2024
Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies
Yizhou Zhang, Ruicheng Wei, Ge Song, et al.
Nature Medicine
|
July 9, 2021
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
Stephen A Harrison, Peter J Ruane, Bradley L Freilich, et al.
Page
of 118
Search research articles
Search
Showing results (941-950 of 1,174) with videos related to
Sort By:
Page
of 118
Current Protein & Peptide Science
|
May 27, 2020
The Advances of the Structure and Function of Indoleamine 2, 3- dioxygenase 1 and Its Inhibitors
Huai-Chuan Duan, Lian-Xin Peng, Yi-Chen Hu, et al.
Environment International
|
October 29, 2021
Heterogeneous viral contribution to dissolved organic matter processing in a long-term macrocosm experiment
Xiaowei Chen, Wei Wei, Xilin Xiao, et al.
Current Medical Science
|
April 28, 2023
Efficacy of Children Neuropsychological and Behavioral Scale in Screening for Autism Spectrum Disorders through a Combination of Developmental Surveillance
Jin-Hui Li, Jin-Zhu Zhao, Li Hua, et al.
Biotechnology and Bioengineering
|
January 14, 2019
Combining orthogonal CRISPR and CRISPRi systems for genome engineering and metabolic pathway modulation in Escherichia coli
Li-Yu Sung, Meng-Ying Wu, Mei-Wei Lin, et al.
Oncotargets and Therapy
|
May 27, 2016
Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis
Yong-Xuan Liu, Xin-Shuai Wang, Yu-Feng Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 30, 2020
Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer
Weili Wang, Martha M Matuszak, Chen Hu, et al.
Experimental Cell Research
|
May 8, 2020
Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia
Cheng Chen, Li Wang, Lili Li, et al.
The Review of Scientific Instruments
|
December 30, 2025
Tabletop pulsed x-ray ghost imaging with a single-pixel detector
Hui Zeng, Ming-Yang Zhu, Xi-Chen Hu, et al.
Mabs
|
November 5, 2024
Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies
Yizhou Zhang, Ruicheng Wei, Ge Song, et al.
Nature Medicine
|
July 9, 2021
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
Stephen A Harrison, Peter J Ruane, Bradley L Freilich, et al.
Page
of 118